Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

[ad_1] Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but…

Bayer Weighs Structural Changes But Rules Out Three-Way Split

[ad_1] Updated Nov. 8, 2023 5:34 am ET Bayer Chief Executive Bill Anderson said he is looking at options to overhaul the company’s structure and remove multiple layers of management…

WSJ News Exclusive | Novartis Pursuit of Cytokinetics Cools

[ad_1] Updated Jan. 11, 2024 12:47 pm ET Novartis has backed away from its pursuit of Cytokinetics, putting a damper on the prospects of a deal for the promising heart-drug…

CVS to close ‘select’ pharmacies in Target stores in the coming months

[ad_1] CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail pharmacy chains in the U.S. struggle to boost profits. …

WSJ News Exclusive | CVS is Closing Pharmacies Inside Some Target Stores

[ad_1] CVS Health plans to close dozens of pharmacies inside Target stores at a time when pharmacy chains are struggling to grow retail profits. CVS will close the pharmacies between…

GSK Expands Respiratory Pipeline With Aiolos Bio Buy

[ad_1] Updated Jan. 9, 2024 3:07 am ET GSK is buying biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline and follows…

WSJ News Exclusive | Tinder Owner Match Draws Elliott Investment

[ad_1] Updated Jan. 8, 2024 9:37 pm ET Elliott Investment Management has built a big stake in Match Group and plans to push the online dating company to take steps…

Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company’s $6 billion forecast

[ad_1] Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up…

QurAlis Opens EU Headquarters In The Netherlands

[ad_1] Last week, QurAlis Corporation announced the opening of its European Union (EU) headquarters in Leiden, The Netherlands. The new location will serve as the hub for the company’s European…

Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion

[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…